SCHEMBL20056601

SCHEMBL20056601

CNC(=O)c1cc(-c2ccc(O)c(Cl)c2)ccc1F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 5/20 0.52
HSD17B2 P37059 5/20 0.52
GAA P10253 1/20 0.46
ESR2 Q92731 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
HDAC2 Q92769 1/20 0.43
PDK2 Q15119 1/20 0.42
KCNMA1 Q12791 1/20 0.42
ESR1 P03372 1/20 0.41
ERCC1 P07992 1/20 0.40
ERCC4 Q92889 1/20 0.40
SCN9A Q15858 1/20 0.40
ACLY P53396 2/20 0.40
NUDT1 P36639 1/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
ESRRG P62508 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20056482 0.80 HSD17B1 (0.47) HSD17B1HSD17B2ESR2SMN1; SMN2HDAC2
SCHEMBL5437372 0.79 GAA (0.50) GAASMN1; SMN2PDK2ACLYNUDT1
SCHEMBL17481527 0.77 GAA (0.58) GAASMN1; SMN2KCNMA1NUDT1KDM4E
SCHEMBL16076888 0.75 HSD17B1 (0.54) HSD17B1HSD17B2ESR2PDK2
SCHEMBL3979604 0.73 CA12 (0.53) HSD17B1HSD17B2SMN1; SMN2PDK2ERCC1
SCHEMBL2102486 0.73 P2RX1 (0.47) GAASMN1; SMN2KCNMA1NUDT1LMNA
SCHEMBL20652569 0.72 GAA (0.50) GAASMN1; SMN2SCN9ANUDT1KDM4E
SCHEMBL7133296 0.72 CES2 (0.61) GAASCN9ANUDT1KDM4ELMNA
SCHEMBL3979148 0.72 ACMSD (0.59) HSD17B1HSD17B2ERCC1ERCC4KDM4E
SCHEMBL3978041 0.71 ERCC1 (0.50) HSD17B1HSD17B2ESR2ESR1ERCC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970353-B1 MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS VERTEX PHARMA (US) 2018-04-18 EP disclosed